Brian Elsbernd Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 23 hours ago
Brian Elsbernd has an estimated net worth of at least $10.3 million*, as of yesterday. They own 271,039 shares of CPRX stock. They have sold 245,897 shares of CPRX stock since 2021, for an estimated $4.8 million.
Brian Elsbernd $CPRX SEC Form 4 Insider Trading
Brian Elsbernd has filed a total of 10 insider trades in $CPRX since 2021. Their most recent trade was a sale of 30,000 shares, made on Sep 08, 2025. Their largest trade was a sale of 53,255 shares, made on Mar 03, 2025. We estimate that they now own 271,039 shares of $CPRX, worth an estimated $5.5 million.
Insider Trading at $CPRX
There have been a total of 126 insider trades reported at $CPRX since 2021, with 0 shares purchased and 7.0 million shares sold. The most active insider traders in $CPRX stock have been Alicia Grande, Patrick J Mcenany, and Brian Elsbernd. The most recent trade was a sale of 30,000 shares reported by Brian Elsbernd (Chief Compliance/Legal Officer), made on Sep 08, 2025.
History of Insider Stock Trades by Brian Elsbernd
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
CPRX
|
Sale | 30,000 | Sep 08, 2025 | Sept. 10, 2025, 5 p.m. |
|
CPRX
|
Sale | 30,000 | Sep 04, 2025 | Sept. 5, 2025, 5 p.m. |
|
CPRX
|
Sale | 20,000 | Sep 03, 2025 | Sept. 5, 2025, 5 p.m. |
|
CPRX
|
Sale | 9,720 | Mar 03, 2025 | March 5, 2025, 6 p.m. |
|
CPRX
|
Sale | 53,255 | Mar 03, 2025 | March 5, 2025, 6 p.m. |
|
CPRX
|
Sale | 9,300 | Nov 26, 2024 | Nov. 29, 2024, 9:08 p.m. |
|
CPRX
|
Sale | 3,956 | Nov 26, 2024 | Nov. 29, 2024, 9:08 p.m. |
|
CPRX
|
Sale | 25,000 | Mar 27, 2024 | March 28, 2024, 4:45 p.m. |
|
CPRX
|
Sale | 50,000 | Mar 20, 2023 | March 22, 2023, 4:45 p.m. |
|
CPRX
|
Sale | 14,666 | Nov 11, 2022 | Nov. 15, 2022, 6 p.m. |
$CPRX Executives and Stock Owners with Insider Trades
-
Alicia Grande, VP, Treasurer and CFO
-
Patrick J Mcenany, President and CEO
-
Brian Elsbernd, Chief Compliance/Legal Officer
-
Gary Ingenito, Chief Med. & Reg. Officer
-
Carmen Jeffrey Del, Chief Commercial Officer
-
Steve Miller, Chief Operating Officer
-
Steve Miller, Chief Op. & Scientific Officer
-
Preethi Sundaram, Chief Strategy Officer
-
Gary Ingenito, Chief Medical & Reg. Officer
-
Richard J Daly, President and CEO
-
Gary Ingenito, Chief Medical Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.